Profilo
Bruce Badner is currently a Senior Investment Analyst at American Century Investment Management, Inc., a position held since 2014.
Former positions include Director at Elan Pharmaceuticals LLC in 2010, Analyst at Goldman Sachs & Co. LLC in 1997, Analyst at Sanford C.
Bernstein & Co. LLC from 2011 to 2014, and Principal at Pfizer Venture Investments LLC in 2005.
Education includes an undergraduate degree (1994) and a graduate degree (1995) from The Trustees of Columbia University in The City of New York, and an MBA from the Massachusetts Institute of Technology (2000).
Posizioni attive di Bruce Badner
| Società | Posizione | Inizio |
|---|---|---|
American Century Investment Management, Inc.
American Century Investment Management, Inc. Investment ManagersFinance ACIM uses a variety of methods of analysis and investment strategies in managing their clients’ assets. These methods of analysis and strategies are generally designed for strategic, long-term investing. Most client portfolios managed by the firm pursue an investment strategy using an equity, fixed income, alternative or multi-asset approach. | Analyst-Equity | 01/01/2014 |
Precedenti posizioni note di Bruce Badner
| Società | Posizione | Fine |
|---|---|---|
Sanford C. Bernstein & Co. LLC
Sanford C. Bernstein & Co. LLC Investment Banks/BrokersFinance Provides brokerage services | Analyst-Equity | 01/01/2014 |
Elan Pharmaceuticals LLC
Elan Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceutical products | Corporate Officer/Principal | 31/12/2010 |
Pfizer Venture Investments LLC
Pfizer Venture Investments LLC Investment ManagersFinance Pfizer Ventures Investments invests in companies located across the globe primarily in the United States. The firm focuses on companies operating in oncology, inflammation & immunology, cardiovascular, metabolic/Obesity and Vaccines sectors. It provides financing for seed, early and growth stage capital requirements with an investment size of USD 5 - 20 million. The firm make follow on financing and also acts as lead investor. | Corporate Officer/Principal | 31/12/2005 |
Goldman Sachs & Co. LLC
Goldman Sachs & Co. LLC Investment Banks/BrokersFinance Provides brokerage services | Corporate Officer/Principal | 31/12/1997 |
Formazione di Bruce Badner
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 7 |
|---|---|
American Century Investment Management, Inc.
American Century Investment Management, Inc. Investment ManagersFinance ACIM uses a variety of methods of analysis and investment strategies in managing their clients’ assets. These methods of analysis and strategies are generally designed for strategic, long-term investing. Most client portfolios managed by the firm pursue an investment strategy using an equity, fixed income, alternative or multi-asset approach. | Finance |
Elan Pharmaceuticals LLC
Elan Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceutical products | Health Technology |
The Trustees of Columbia University in The City of New York
The Trustees of Columbia University in The City of New York Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Goldman Sachs & Co. LLC
Goldman Sachs & Co. LLC Investment Banks/BrokersFinance Provides brokerage services | Finance |
Sanford C. Bernstein & Co. LLC
Sanford C. Bernstein & Co. LLC Investment Banks/BrokersFinance Provides brokerage services | Finance |
Massachusetts Institute of Technology
Massachusetts Institute of Technology Finance/Rental/LeasingFinance Functions as a College/University | Finance |
Pfizer Venture Investments LLC
Pfizer Venture Investments LLC Investment ManagersFinance Pfizer Ventures Investments invests in companies located across the globe primarily in the United States. The firm focuses on companies operating in oncology, inflammation & immunology, cardiovascular, metabolic/Obesity and Vaccines sectors. It provides financing for seed, early and growth stage capital requirements with an investment size of USD 5 - 20 million. The firm make follow on financing and also acts as lead investor. | Finance |
















